PMC:7306567 / 12555-12784 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"124","span":{"begin":113,"end":118},"obj":"Chemical"},{"id":"125","span":{"begin":201,"end":206},"obj":"Chemical"}],"attributes":[{"id":"A124","pred":"tao:has_database_id","subj":"124","obj":"MESH:D001393"},{"id":"A125","pred":"tao:has_database_id","subj":"125","obj":"MESH:D001393"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Patients who test positive require anti-Aspergillus therapy, and the BAL fluid sample should be fast-tracked for azole resistance testing by PCR (and culture when positive) in regions with high (\u003e 5%) azole resistance rates [34]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T77","span":{"begin":13,"end":17},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T78","span":{"begin":130,"end":137},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T79","span":{"begin":225,"end":227},"obj":"http://purl.obolibrary.org/obo/CLO_0001302"}],"text":"Patients who test positive require anti-Aspergillus therapy, and the BAL fluid sample should be fast-tracked for azole resistance testing by PCR (and culture when positive) in regions with high (\u003e 5%) azole resistance rates [34]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T67","span":{"begin":69,"end":72},"obj":"Chemical"},{"id":"T68","span":{"begin":113,"end":118},"obj":"Chemical"},{"id":"T69","span":{"begin":201,"end":206},"obj":"Chemical"}],"attributes":[{"id":"A67","pred":"chebi_id","subj":"T67","obj":"http://purl.obolibrary.org/obo/CHEBI_64198"},{"id":"A68","pred":"chebi_id","subj":"T68","obj":"http://purl.obolibrary.org/obo/CHEBI_68452"},{"id":"A69","pred":"chebi_id","subj":"T69","obj":"http://purl.obolibrary.org/obo/CHEBI_68452"}],"text":"Patients who test positive require anti-Aspergillus therapy, and the BAL fluid sample should be fast-tracked for azole resistance testing by PCR (and culture when positive) in regions with high (\u003e 5%) azole resistance rates [34]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T81","span":{"begin":0,"end":229},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Patients who test positive require anti-Aspergillus therapy, and the BAL fluid sample should be fast-tracked for azole resistance testing by PCR (and culture when positive) in regions with high (\u003e 5%) azole resistance rates [34]."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T91","span":{"begin":69,"end":78},"obj":"UBERON:0006314"},{"id":"T92","span":{"begin":113,"end":118},"obj":"CHEBI:68452;CHEBI:68452"},{"id":"T93","span":{"begin":201,"end":206},"obj":"CHEBI:68452;CHEBI:68452"},{"id":"T22792","span":{"begin":69,"end":78},"obj":"UBERON:0006314"},{"id":"T68159","span":{"begin":113,"end":118},"obj":"CHEBI:68452;CHEBI:68452"},{"id":"T29336","span":{"begin":201,"end":206},"obj":"CHEBI:68452;CHEBI:68452"}],"text":"Patients who test positive require anti-Aspergillus therapy, and the BAL fluid sample should be fast-tracked for azole resistance testing by PCR (and culture when positive) in regions with high (\u003e 5%) azole resistance rates [34]."}

{"project":"2_test","denotations":[{"id":"32572532-30580035-47963427","span":{"begin":225,"end":227},"obj":"30580035"},{"id":"T67090","span":{"begin":225,"end":227},"obj":"30580035"}],"text":"Patients who test positive require anti-Aspergillus therapy, and the BAL fluid sample should be fast-tracked for azole resistance testing by PCR (and culture when positive) in regions with high (\u003e 5%) azole resistance rates [34]."}